FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.
Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback